Layman Alexander J, Alsbrook Scott M, Koturbash Igor K, McGill Mitchell R
Department of Environmental Health Sciences, Fay W. Boozman College of Public Health, University of AR for Medical Sciences, Little Rock, AR, USA.
Center for Dietary Supplements Research, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
J Diet Suppl. 2025;22(1):105-122. doi: 10.1080/19390211.2024.2335573. Epub 2024 Apr 1.
Acetaminophen (APAP) overdose is one of the most common causes of acute liver injury. The current standard-of-care treatment for APAP hepatotoxicity, -acetyl--cysteine, is highly effective when administered early after overdose, but loses efficacy in later-presenting patients. As a result, there is interest in the identification of new treatments for APAP overdose patients. Natural products are a promising source of new treatments because many are purported to have hepatoprotective effects. In fact, a great deal of research has been done to identify natural products that can protect against APAP-induced liver injury. However, serious concerns have been raised about the rigor and human relevance of these studies. Here, we systematically reviewed the APAP-natural product literature from 2013 to 2023 to determine the veracity of these concerns and the scope of the potential problem. The results substantiate the concerns that have been previously raised and point to concrete steps that can be taken to improve APAP-natural product research.
对乙酰氨基酚(APAP)过量是急性肝损伤最常见的原因之一。目前针对APAP肝毒性的标准治疗药物N - 乙酰半胱氨酸,在过量服用后早期给药时非常有效,但对就诊较晚的患者则失去疗效。因此,人们对为APAP过量患者确定新的治疗方法很感兴趣。天然产物是新治疗方法的一个有前景的来源,因为许多天然产物据称具有肝脏保护作用。事实上,已经进行了大量研究来确定能够预防APAP诱导的肝损伤的天然产物。然而,这些研究的严谨性和与人类的相关性引发了严重担忧。在这里,我们系统地回顾了2013年至2023年关于APAP与天然产物的文献,以确定这些担忧的真实性以及潜在问题的范围。结果证实了先前提出的担忧,并指出了可以采取的具体措施来改进APAP与天然产物的研究。